Le Lézard
Classified in: Health
Subjects: CCA, FVT

LHC Group announces third quarter 2020 earnings release and conference call dates

LAFAYETTE, La., Oct. 14, 2020 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) today announced details for the release of its results for the third quarter ended September 30, 2020.

LHC Group plans to issue its earnings release after the market closes on Wednesday, November 4, 2020, and will host a conference call on Thursday, November 5, 2020, at 10:00 a.m. Eastern time. The toll-free number to call for this interactive teleconference is (877) 870-4263 (international callers: (412) 317-6011). A telephonic replay of the conference call will be available through midnight on Thursday, November 12, 2020, by dialing (877) 344-7529 (international callers: (412) 317-0088) and entering confirmation number 10148535.

A live webcast of LHC Group's conference call will be available under the Investor Relations section of the Company's website, www.LHCGroup.com. A one-year online replay will be available approximately one hour following the conclusion of the live broadcast.

About LHC Group, Inc.
LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the nation, offering quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. The company's 32,000 employees deliver home health, hospice, home and community based services, and facility-based care in 35 states and the District of Columbia ? reaching 60 percent of the U.S. population aged 65 and older. As the preferred joint venture partner for almost 400 leading U.S. hospitals and health systems, LHC Group works in cooperation with providers to customize each partnership and reach more patients and families with an effective and efficient model of care.


Eric Elliott

Senior Vice President of Finance

(337) 233-1307



SOURCE LHC Group, Inc.

These press releases may also interest you

at 03:41
Baby Ebenezer is a happy, healthy 8-week-old - and an IVF success story of a new kind. His entry into the world was aided by artificial intelligence (AI) applied to medical imaging. As an embryo, Ebenezer was identified within his cohort to be the...

at 03:30
"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: Global Orphan Drug Market Opportunity: US$ 300 Billion US Dominates Global Orphan Drug Market: 50% Market Share US Orphan Drug Opportunity To Surpass: US$ 150...

at 03:15
ViiV Healthcare and Shutterstock Studios today announced the launch of a new online photo gallery ?HIV in View', produced by Shutterstock in collaboration with ViiV Healthcare. The collection, curated with the support of people living with HIV,...

at 03:05
Sosei Group Corporation ("the Company") (TSE: 4565) announces it has entered into a global collaboration and license agreement with Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven", NYSE: BHVN). Under the agreement, Biohaven will receive...

at 03:05
In sync with Giving Tuesday, Warriors Heart Foundation announces Warriors Heart Alumni and U.S. Army Master Sergeant (ret) Teddy Lanier is the new Executive Director of the Warriors Heart Foundation. The Warriors Heart Foundation is a 501(c)(3) that...

at 03:00
Actimed Therapeutics, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, today announces that it has been granted US patent US 10,828,270 expanding its intellectual...

News published on 14 october 2020 at 07:00 and distributed by: